Andrx Generic Prilosec Clears FDA; Approval Could Expedite Patent Litigation
Executive Summary
Andrx expects that FDA's approval of its generic Prilosec (omeprazole) could accelerate the company's patent litigation with AstraZeneca
You may also be interested in...
Purepac Gabapentin Is “First Generic” After Pfizer Delists Neurontin Patent
Purepac and Ivax will split "first generic" 180-day exclusivity on their versions of Pfizer's antiepileptic Neurontin (gabapentin)
Purepac Gabapentin Is “First Generic” After Pfizer Delists Neurontin Patent
Purepac and Ivax will split "first generic" 180-day exclusivity on their versions of Pfizer's antiepileptic Neurontin (gabapentin)
Generic Neurontin: Hurdles To TorPharm Approval Expected To Clear In Jan.
Pfizer's Neurontin (gabapentin) could face generic competition as early as mid-January